Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Long-Term Debt Repayments (2019 - 2022)

Lipocine (LPCN) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $833333.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Long-Term Debt Repayments changed 0.0% year-over-year to $833333.0, compared with a TTM value of $1.7 million through Dec 2022, down 50.0%, and an annual FY2022 reading of $1.7 million, down 50.0% over the prior year.
  • Long-Term Debt Repayments was $833333.0 for Q2 2022 at Lipocine, roughly flat from $833334.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $833335.0 in Q2 2019 and bottomed at $277778.0 in Q2 2020.
  • Average Long-Term Debt Repayments over 4 years is $769230.8, with a median of $833333.0 recorded in 2019.
  • The sharpest move saw Long-Term Debt Repayments crashed 66.67% in 2020, then soared 200.0% in 2021.
  • Year by year, Long-Term Debt Repayments stood at $833334.0 in 2019, then tumbled by 33.33% to $555556.0 in 2020, then surged by 50.0% to $833333.0 in 2021, then changed by 0.0% to $833333.0 in 2022.
  • Business Quant data shows Long-Term Debt Repayments for LPCN at $833333.0 in Q2 2022, $833334.0 in Q1 2022, and $833333.0 in Q4 2021.